Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.
Human ADA3, the evolutionarily conserved transcriptional co-activator, remains the unified part of multiple cellular functions, including regulation of nuclear receptor functions, cell proliferation, apoptosis, senescence, chromatin remodelling, genomic stability and chromosomal maintenance. The past decade has witnessed exciting findings leading to considerable expansion in research related to the biology and regulation of hADA3. Embryonic lethality in homozygous knockout Ada3 mouse signifies the importance of this gene product during early embryonic development. Moreover, the fact that it is a novel target of Human Papillomavirus E6 oncoprotein, one of the most prevalent causal agents behind cervical cancer, helps highlight some of the crucial aspects of HPV-mediated oncogenesis. These findings imply the central involvement of hADA3 in regulation of various cellular functional losses accountable for the genesis of malignancy and viral infections. Recent reports also provide evidence for post-translational modifications of hADA3 leading to its instability and contributing to the malignant phenotype of cervical cancer cells. Furthermore, its association with poor prognosis of breast cancer suggests intimate association in the pathogenesis of the disease. Here, we present the first review on hADA3 with a comprehensive outlook on the molecular and functional roles of hADA3 to provoke further interest for more elegant and intensive studies exploring assorted aspects of this protein.
Department of Biochemistry, University of Delhi South Campus, New Delhi, 110021, India.
Vaibhav
V
Chand
Department of Biochemistry, University of Delhi South Campus, New Delhi, 110021, India.
Deeptashree
D
Nandi
Department of Biochemistry, University of Delhi South Campus, New Delhi, 110021, India.
Anita Garg
AG
Mangla
Department of Biochemistry, University of Delhi South Campus, New Delhi, 110021, India.
Puneet
P
Sharma
Department of Biochemistry, University of Delhi South Campus, New Delhi, 110021, India alonag22@gmail.com.
Alo
0000-0002-8433-9209
A
Nag
D000818:Animals; D017209:Apoptosis; D063646:Carcinogenesis; D049109:Cell Proliferation; D047108:Embryonic Development; D005260:Female; D006801:Humans; D051379:Mice; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism*; D027383:Papillomaviridae / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D015533:Transcriptional Activation; D002583:Uterine Cervical Neoplasms / Q000473:pathology
D009856:Oncogene Proteins, Viral; C444103:TADA3 protein, human; D014157:Transcription Factors
ADA3; cancer; co-activator; development; genomic stability